Mechanistically, LL-37 stimulates MSCs to secrete larger amounts of inflammatory and pro-angiogenic factors, such as IL-1 receptor antagonist, IL-6, IL-10, CCL5, VEGF, and MMP-2, and this phenomenon is closely associated with the promotion of ovarian cancer progression and metastasis [70]. The gene discussed is MMP2; the disease is ovarian cancer.